InvestSMART

Alterity Therapeutics Limited (ASX:ATH)

ALERT: Price-sensitive ASX Announcement for ATH
Current share price for ATH : $0.670 0.661 (7,344.44%)+
Announcement
Release
29 Apr 2026 12:54PM
Price at Release
$0.009
Full Release
download
Summary
The document is a Notice of General Meeting for Alterity Therapeutics Limited, scheduled to be held on 29 May 2026. The meeting includes several resolutions: the election of directors Mr. Julian Babarczy and Ms. Ann Cunningham, the consolidation of capital by a ratio of 50 to 1 for shares and options, and the issuance of options to Mr. Julian Babarczy and Montoya Pty Ltd ATF Buttercup Trust. Also included are proposed amendments to the company's constitution to set an issue cap for securities at 10% under the incentive plan, and approval to issue securities under an incentive plan. The purpose of these resolutions is to align management interests with shareholders, motivate key personnel, and streamline capital management.
Key Points
  • General Meeting scheduled for 29 May 2026
  • Election of directors Mr. Julian Babarczy and Ms. Ann Cunningham
  • Consolidation of capital on a 50 to 1 basis for shares and options
  • Approval to issue up to 100,000,000 options to Mr. Julian Babarczy
  • Approval to issue up to 50,000,000 options to Montoya Pty Ltd ATF Buttercup Trust
  • Amendment to the constitution to include a new clause setting a 10% issue cap for securities under the Plan
  • Approval to issue up to 1,087,541,633 Securities under an incentive plan
  • Voting exclusion and prohibition statements apply to certain resolutions
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.